§ 53-10-310. Practice Sites Where a Controlled Substance Dispensed Required to Provide for Electronic Access to the Controlled Substance Database — Exceptions — Violations and Penalties
Each person or entity operating a practice site where a controlled substance is prescribed or dispensed to a human patient shall provide for electronic access to the database at all times when a healthcare practitioner provides healthcare services to a human patient potentially receiving a controlled substance. This section shall not apply to any person […]
§ 53-10-311. Establishment of Operations Committee — Agreements With Federal Government and Other Jurisdictions for Sharing and Dissemination of Data and Information
There is created an operations committee. The committee shall be composed of: The board of medical examiners’ medical director for special projects; An epidemiologist employed by the department of health; The executive director of the board of pharmacy; The director of the controlled substance database; A member of the controlled substance database committee; The executive […]
§ 53-10-312. Minimum Reporting Requirements for Wholesalers and Manufacturers — Establishment of Rules as to Reporting Requirements
Wholesalers and manufacturers, as defined in § 63-10-204, that sell controlled substances at wholesale must at least report the following information to the committee in Automation of Reports and Consolidated Orders System (ARCOS) format or other mutually acceptable format: Wholesaler or manufacturer with a drug enforcement administration registration number; provided, that if this number is […]
§ 53-10-401. Tamper-Proof Prescriptions
All prescriptions written or printed by practitioners authorized to write prescriptions in this state shall be written on either tamper-resistant prescription paper or printed utilizing a technology that results in a tamper-resistant prescription that meets the current centers for medicare and medicaid services guidance to state medicaid directors regarding § 7002(b) of the United States […]
§ 53-11-201. Procedure in Confiscation
In all cases of seizure of any narcotic drugs or marijuana or any vehicle, aircraft or boat or other property subject to forfeiture under this chapter, the officer or other person making the seizure shall deliver a receipt to the person, if any, found in possession of the property or conveyance. The receipt shall state […]
§ 53-11-203. Procedure Final When No Claim Interposed
If no claim is interposed, narcotic drugs, marijuana or other property shall be forfeited without further proceedings and the drugs, marijuana or other property shall be sold or disposed of as provided in this chapter.
§ 53-11-204. Disposition of Proceeds
The proceeds of all seizures, confiscations and sales made by a state agency pursuant to this chapter shall be transmitted to the state treasurer and deposited in the state treasury; provided, that upon application of the commissioner, the proceeds or any part of the proceeds may be allocated by the commissioner of finance and administration […]
§ 53-11-301. Rules and Fees for Controlled Drugs
The board of pharmacy and the appropriate occupational or professional licensing board governing persons who may legally dispense controlled substances may promulgate rules and charge reasonable fees relating to the registration and control of the manufacture, distribution, dispensing, warehousing of, and the provision of logistics services for controlled substances within this state.
§ 53-10-210. Prescription Drugs for Epilepsy Patients
As used in this section, unless the context otherwise requires: “Anti-epileptic drug” means: Any drug prescribed for the treatment of epilepsy; or A drug used to treat or prevent seizures; “Epilepsy” means a neurological condition characterized by recurrent seizures; “Interchange” means the dispensing of one (1) manufacturer of an anti-epileptic drug for a different manufacturer […]
§ 53-10-211. Interchangeable Biological Products
A prescriber shall allow for substitution with an interchangeable biological product of a prescribed biological product under all circumstances unless: The prescriber determines the medical necessity of a prescribed biological product due to: An adverse reaction previously experienced by the patient to an interchangeable biological product; An interchangeable biological product having previously been demonstrated as […]